R1 RCM Inc. (RCM) Q2 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects a mixed sentiment. The positive aspects include a 12% revenue growth and successful integration of Acclara, but the absence of 2024 guidance and the impact of cyberattacks are concerning. The lack of guidance is particularly negative, and the cybersecurity risks and increased operational costs further dampen sentiment. The slight outperformance in Adjusted EBITDA is a positive, but the overall picture is clouded by uncertainties and risks, resulting in a neutral outlook for the stock price over the next two weeks.
Key Financial Performance
Revenue $627.9 million, up 12% year-over-year, primarily driven by the contribution of Acclara and continued growth in the Modular business.
Adjusted EBITDA $156.1 million, slightly ahead of internal expectations, demonstrating continued cost discipline and operational initiatives.
Net Operating Fees $374.6 million, up approximately 5% year-over-year, driven by Acclara's contribution and better-than-expected volumes in the enterprise customer base.
Incentive Fees $21.7 million, slightly below expectations due to a $4 million impact related to outages.
Modular and Other Revenue $231.6 million, up 35% year-over-year, driven by Acclara revenues and growth in Modular business.
Non-GAAP Cost of Services Approximately $421 million, up roughly $57 million year-over-year, primarily due to Acclara inclusion; flat excluding Acclara.
Non-GAAP SG&A Expenses $50.8 million, down approximately $3 million year-over-year, due to lower allowances for credit losses.
Cash and Cash Equivalents $163 million at the end of June, down from $173.6 million at the end of December.
Cash from Operations $36.8 million generated in the quarter.
Net Debt $2.1 billion, including a paydown of $75 million in revolver borrowed related to the Change Healthcare incident.
Liquidity Approximately $682 million at the end of June, from cash on the balance sheet and borrowing capacity.
Other Expenses $34.3 million, including $14 million of integration-related costs and $6.3 million related to a one-time vendor termination fee.
Operating Highlights
New Product Offerings: Recent examples include insurance discovery, modular coding, and patient receivable solutions, each of which enables lower cost and expands revenue for providers.
Generative AI Innovations: The automated clinical appeals application assists clinical experts by reading medical records for clinically denied claims, reducing time spent from one hour to 15 minutes.
Customer Base Expansion: Successfully completed onboarding of over 1,900 associates for a new end-to-end customer, with revenue ramp-up expected in the second half of the year.
Cross-Selling Opportunities: Active meetings with Acclara's customer base to explore additional cross-selling opportunities.
Modular Solutions Growth: Added charge capture and underpayment solutions anticipated to generate several million dollars in additional annual revenue.
Operational Efficiency: Demonstrated operational agility in response to the Ascension cyberattack, implementing manual processes to manage the backlog.
Integration Progress: Integration of Acclara is on track, with confidence in achieving stated synergy objectives.
Strategic Shift: Focus on technology transformation and operational efficiencies to enhance global capabilities and infrastructure.
Market Positioning: Positioned as the leading revenue cycle partner in the industry, emphasizing customer-centric approach and innovation.
Risk or Challenges
Cybersecurity Risks: Recent cyberattacks, including those affecting Change Healthcare and Ascension, have impacted business operations and financial results. The company has incurred additional operational costs due to these incidents.
Integration Challenges: The integration of Acclara is ongoing, with potential risks related to achieving anticipated synergies and operational objectives.
Customer Retention and Acquisition: There are risks associated with retaining existing customers and acquiring new ones, particularly in light of recent disruptions and market conditions.
Economic Factors: Economic downturns and high inflation may affect market conditions and overall business performance.
Revenue Impact from Outages: The Ascension outage is expected to result in a revenue impact of $75 million to $95 million for the full year, primarily due to delays in cash collections.
Increased Operational Costs: The company anticipates incurring $10 million to $15 million in additional costs in the second half of the year related to the Ascension outage, primarily due to overtime and labor for backlog resolution.
Competitive Pressures: The company faces competition in the revenue cycle management market, which may affect its ability to grow and retain market share.
Guidance & Outlook
Revenue Growth: Total revenue grew by 12% year-over-year, primarily driven by the contribution of Acclara and continued growth in Modular business.
Adjusted EBITDA: Adjusted EBITDA for the quarter was $156.1 million, slightly ahead of internal expectations.
Integration Progress: The integration of Acclara continues to progress, with confidence in achieving stated synergy objectives.
Operational Agility: The company demonstrated significant operational agility and scale in response to recent cyberattacks.
Technology Transformation: Continued advancement in technology transformation, including AI and automation.
Customer Onboarding: Successfully completed onboarding of over 1,900 associates for a new end-to-end customer.
Modular Solutions Expansion: Expanded relationships with existing customers, including a $400 million NPR regional hospital.
2024 Guidance: In light of the pending transaction, no guidance for 2024 is provided.
Revenue Impact from Cyber Incident: Expect full-year revenue impact of the Ascension outage to be between $75 million to $95 million, primarily affecting net operating fees.
Incremental Costs from Cyber Incident: Expect to incur $10 million to $15 million in incremental costs in the second half of the year due to the Ascension outage.
Long-term Impact: No long-term impact expected on core operations due to the Ascension outage; recovery anticipated in 2025.
Shareholder Return Plan
Shareholder Return Plan: In light of the pending transaction, R1 RCM Inc. is not providing guidance for 2024, which includes any updates on potential share buyback or dividend programs.
Key Q&A
Earnings Word Cloud
RCM Transcript
The earnings call reflects a mixed sentiment. The positive aspects include a 12% revenue growth and successful integration of Acclara, but the absence of 2024 guidance and the impact of cyberattacks are concerning. The lack of guidance is particularly negative, and the cybersecurity risks and increased operational costs further dampen sentiment. The slight outperformance in Adjusted EBITDA is a positive, but the overall picture is clouded by uncertainties and risks, resulting in a neutral outlook for the stock price over the next two weeks.
The earnings call presents a positive outlook with strong cash flow improvements, successful integration of Cloudmed, and AI-driven strategies. Despite some uncertainties in project timelines, the expected growth in adjusted EBITDA and synergies from acquisitions indicate promising future prospects. The market is likely to react positively to these developments.
The earnings call highlighted strong financial metrics, including a 30% YoY increase in adjusted EBITDA and substantial cash flow from operations. The partnership with Microsoft is a positive catalyst, and the modular business is growing robustly. Despite credit losses, future expectations are optimistic. The Q&A section revealed confidence in new business opportunities and clarified concerns raised by a short report. Overall, the positive factors outweigh concerns, suggesting a positive stock price movement.
RCM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
